President-elect Donald Trump announced last Thursday, Nov. 14, that Kennedy, 70, was his pick to head the Department of ...

Produced in Chinese hamster ovary cells, Ziihera (zanidatamab-hrii) is the first HER2-targeted bispecific antibody treatment for patients with previously treated, unresectable or metastatic biliary ...

FDA Sets Review Date for Gene Therapy for Enzyme Deficiency ...

After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked ...

The FDA has approved UCB's Bimzelx for moderate-to-severe hidradenitis suppurativa, offering a new treatment option for this ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with ...

FDA Sets Review Date for Gene Therapy for Enzyme Deficiency ...

Medicare fraud costs Americans about $60 billion each year and healthcare plans are stepping in spread awareness and stop ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

A total of 17 lots are now part of the recall of Clonazepam because some cartons have the wrong strength on the label.

Patients with pulmonary arterial hypertension often experienced delays in obtaining a correct diagnosis. The American Lung ...